PATENT CLAIM ANALYSIS

Application Number: 15762508
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "04400A"]

Abstract:
The present invention provides miR-19 modulators and uses thereof, such as for promoting angiogenesis and/or wound healing with miR-19 inhibitors alone or in combination with other agents. The present invention also provides methods of treating or preventing arterial and cardiac conditions with a miR-19 inhibitor. Also provided are oligonucleotides with chemical motifs that are miR-19 inhibitors, and methods of using the oligonucleotides for inhibiting the function or activity of miR-19 in a subject in need thereof.

Claim (Index 20):
The oligonucleotide inhibitor of any one of  claims 17 - 19 , wherein the locked nucleic acid (LNA) nucleotides has a 2\u2032 to 4\u2032 methylene bridge.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 90.0
- Lexical Diversity: 1.58824
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15878176', '15154711', '13924340', '15714671', '13327507']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8211639725344627
- 35 USC 102 Novelty (BERT): 0.5642120907005033
- Combined Prediction Score: 0.7954687843510668
- Mean Citation Score: 399.333386
- Max Citation Score: 468.14435
- Similarity Product: 350.02772435771226

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test